T-cell receptor recognition of Outer Membrane Protein Complex (OMPC)-derived peptide–MHC class II complexes (TCR-OMPC-MHC II)

The recognition of Outer Membrane Protein Complex (OMPC)-derived peptides presented on MHC class II molecules by CD4+ T-cell receptors (TCR) is a fundamental immunological interaction utilized in conjugate vaccine design. OMPC, sourced from Neisseria meningitidis serogroup B, acts as a potent carrier protein that facilitates a T-cell dependent immune response against covalently attached polysaccharide antigens (Donnelly et al., 1990, Journal of Immunology). Upon vaccination, B cells specific to the polysaccharide component internalize the conjugate, proteolytically process the OMPC protein, and display its peptides on the cell surface via MHC class II molecules. Specific CD4+ T cells recognize these peptide-MHC complexes through their TCRs, providing essential 'help' to B cells, which facilitates immunoglobulin class switching and the generation of long-term immunological memory. This mechanism is particularly vital for inducing protective immunity in infants against pathogens such as Haemophilus influenzae type b, as seen in vaccines like PedvaxHIB (FDA, 2021). Understanding this TCR-peptide-MHC II interaction is crucial for optimizing vaccine efficacy and ensuring robust protection across diverse patient populations.

Other names

OMPC-peptide-MHC II complexT-cell receptor-OMPC interactionOuter membrane protein complex-specific T-cell activationPorB-peptide-MHC II complex

The OMPC carrier protein is processed by antigen-presenting cells (APCs), such as B cells, into peptides that are loaded onto MHC class II molecules; these complexes are then recognized by specific CD4+ T-cell receptors, which triggers the release of cytokines and provides costimulatory signals necessary for B-cell differentiation and high-affinity antibody production (Pollard et al., 2009, Nature Reviews Immunology).